TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - COLOPLAST B Stock

Certificat

DE000SW1K3V7

Market Closed - Deutsche Boerse AG 03:38:11 2024-07-16 pm EDT
6.66 EUR +0.45% Intraday chart for TURBO UNLIMITED LONG- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - COLOPLAST B
Current month+4.25%
1 month+2.16%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-07-16 6.66 +0.45%
24-07-15 6.63 -2.93%
24-07-12 6.83 -0.73%
24-07-11 6.88 +1.78%
24-07-10 6.76 +4.00%

Delayed Quote Deutsche Boerse AG

Last update July 16, 2024 at 03:38 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying COLOPLAST A/S
IssuerLogo Issuer Société Générale Société Générale
WKN SW1K3V
ISINDE000SW1K3V7
Date issued 2023-07-27
Strike 371.3 kr
Maturity Unlimited
Parity 10 : 1
Emission price 6.33
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 8.29
Lowest since issue 4.41

Company Profile

Coloplast A/S specializes in the design, manufacturing, and marketing of disposable medical products. Net sales break down by family of products as follows: - hygiene products (43.4%): urine bags, plugs, urinary testing systems and sets, etc.; - ostomy care products (36.8%): bags and equipment used following intestinal operations; - wound care and skincare products (11.9%): wound dressings, bandages, creams and gels; - voice and respiratory care products (7.9%): voice prostheses for speaking, adhesives, laryngectomy cannulas for breathing, hands-free speaking devices, etc. Net sales are distributed geographically as follows: Denmark (1.4%), the United States (21%), the United Kingdom (14%), France (10.8%) and other (52.8%).
Sector
-
More about the company

Ratings for Coloplast A/S

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Coloplast A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
868.6 DKK
Average target price
899.2 DKK
Spread / Average Target
+3.52%
Consensus